← Back to headlines
Fresenius Shareholders Demand Answers on Vamed Investigation
Shareholders of the healthcare group Fresenius expressed approval for a slightly increased dividend at the general meeting but raised critical questions regarding its former subsidiary, Vamed.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
